• The Group
  • News and Events
  • Investor relations
    • Financial Information
      • Financial Reports
      • Financial Calendar
    • Directors
      • Executive Management
      • Board
    • Stock Information
      • Analyst Coverage
      • Stock Charts
    • Shareholder Information
      • General Meetings
      • Other Regulated Information
    • Advisor & Investor Contact
      • Investor Contacts
      • Advisors
    • Other Information
      • AIM Admission Document
      • AIM Rule 26
      • Investor Presentation
  • Careers
  • Contact
  • Corporate Presentations
    • Annual Report 2020
    • Investor Presentation 2020
    • Investor Event 2021
    • Investor Event Q&A 2021
    • AGM 2021
    • AGM Results 2021
English

Choose your language:

  • Français
21/12/18Posted in Board, Novacyt Group, Products, Uncategorized

Novacyt launches two new CE-IVD Marked molecular diagnostic kits

Novacyt launches two new molecular CE Mark assays

First of an expanding menu of tests for monitoring post-transplantation and immunosuppressed patients

© 2021 Novacyt Group.   Privacy | Copyright | Terms and Conditions
  • Connect with us